Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PT Metro Healthcare Indonesia Tbk EV-to-EBITDA?
PT Metro Healthcare Indonesia TbkISX:CARE 71 EV-to-EBITDA is 142.20 as of Aug. 30, 2026, which is 9% below its 10-year median of 156.83. GuruFocus rates ISX:CARE with a GF Score™ of 71/100 and a GF Value™ of Rp367.69 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 515 Healthcare Providers & Services companies, PT Metro Healthcare Indonesia Tbk ranks worse than 98.06% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PT Metro Healthcare Indonesia Tbk's enterprise value is Rp15,356,536 Mil.
PT Metro Healthcare Indonesia Tbk's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was Rp107,995 Mil. Therefore, PT Metro Healthcare Indonesia Tbk's EV-to-EBITDA for today is 142.20.
The historical rank and industry rank for PT Metro Healthcare Indonesia Tbk's EV-to-EBITDA or its related term are showing as below:
ISX:CARE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -6370.14 Med: 156.83 Max: 6092.36
Current: 142.2
During the past 10 years, the highest EV-to-EBITDA of PT Metro Healthcare Indonesia Tbk was 6092.36. The lowest was -6370.14. And the median was 156.83.
ISX:CARE's EV-to-EBITDA is ranked worse than 98.06% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.62
vs ISX:CARE: 142.20
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Metro Healthcare Indonesia Tbk's PE Ratio (TTM) for today is calculated as:
PT Metro Healthcare Indonesia Tbk's share price for today is Rp444.00.
PT Metro Healthcare Indonesia Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0.178.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk EV-to-EBITDA Chart
ISX:CARE vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's EV-to-EBITDA falls into.
PT Metro Healthcare Indonesia Tbk's current Enterprise Value is Rp15,356,536 Mil.
PT Metro Healthcare Indonesia Tbk's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp107,995 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a EV-to-EBITDA of 142.20 as of Aug. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PT Metro Healthcare Indonesia Tbk. This is near median its historical median of 156.83. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #505 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 98.1%.
Is PT Metro Healthcare Indonesia Tbk's EV-to-EBITDA too high?
PT Metro Healthcare Indonesia Tbk's current EV-to-EBITDA of 142.20 is near median its 10-year median of 156.83. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.62. PT Metro Healthcare Indonesia Tbk's value of 142.20 is 1239% above this industry median. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #505 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #505 out of 515 companies for EV-to-EBITDA. This places PT Metro Healthcare Indonesia Tbk in the lower half of its industry. The industry median EV-to-EBITDA is 10.62. PT Metro Healthcare Indonesia Tbk's value of 142.20 is 1239% above this benchmark. While the company's 10-year median is 156.83 vs. the industry median of 10.62, PT Metro Healthcare Indonesia Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.62, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Metro Healthcare Indonesia Tbk's current EV-to-EBITDA of 142.20 is 1239% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PT Metro Healthcare Indonesia Tbk. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current EV-to-EBITDA is 142.20, which is near median its own 10-year median of 156.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp367.69, compared to a current price of Rp444.00 — trading 20.8% above its estimated fair value. The current EV-to-EBITDA is 142.20, which is near median its 10-year median of 156.83 and 1239% above the Healthcare Providers & Services industry median of 10.62. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current EV-to-EBITDA is 142.20 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp444.00 is trading 20.8% above its estimated GF Value™ of Rp367.69.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
EV-to-EBITDA: 142.20 (near median its 10-year median of 156.83)
GF Value™: Rp367.69 vs. price of Rp444.00 (20.8% above fair value)
Industry Position: 1239% above the Healthcare Providers & Services median (#505 of 515)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
71GF Score
Get the complete analysis for ISX:CARE
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
